Cipla share news and announcements
NSE: CIPLABSE: 500087Pharmaceuticals & BiotechnologyLarge Cap
Share price at the NSE close on 23 Oct 2026. Previous close ₹1,330.90.
- Next results date: the board meets on 27 Oct 2026 to consider: financial results.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹1,08,093 Cr99th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 23 Jul 2026
- 32.1
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 13 May 2026
- 3.1
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.97%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 23 Jul 2026
- 10.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 23 Jul 2026
- 11.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 13 May 2026
- 0.01
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 13,23,90058.1% delivered
Cipla analyst meets
278 filed, newest first. Page 1 of 6.
Oct 2026
13 Oct · Analysts
Aug 2026
27 Aug · Analysts
Jul 2026
8 Jul · Analysts
Jun 2026
2 Jun · Analysts
May 2026
28 May · Analysts
Apr 2026
16 Apr · Analysts
Feb 2026
17 Feb · Analysts
4 Feb · Analysts
Jan 2026
9 Jan · Analysts
Oct 2025
23 Oct · Analysts
13 Oct · Analysts
Sep 2025
10 Sep · Analysts
Aug 2025
Jul 2025
10 Jul · Analysts
Jun 2025
30 Jun · Analysts
May 2025
Apr 2025
30 Apr · Analysts
30 Apr · Analysts
17 Apr · Analysts
Feb 2025
10 Feb · Analysts
Jan 2025
8 Jan · Analysts
Oct 2024
9 Oct · Analysts
Aug 2024
20 Aug · Analysts
5 Aug · Analysts
3 Aug · Analysts
Jul 2024
19 Jul · Analysts
12 Jul · Analysts
May 2024
28 May · Analysts
9 May · Analysts
Apr 2024
5 Apr · Analysts
Mar 2024
6 Mar · Analysts
5 Mar · Analysts
Jan 2024
9 Jan · Analysts
Dec 2023
1 Dec · Analysts
Nov 2023
28 Nov · Analysts
Oct 2023
7 Oct · Analysts
Aug 2023
14 Aug · Analysts
Jul 2023
7 Jul · Analysts
Apr 2023
28 Apr · Analysts
Mar 2023
29 Mar · Analysts
2 Mar · Analysts
Feb 2023
28 Feb · Analysts
24 Feb · Analysts
17 Feb · Analysts
13 Feb · Analysts
8 Feb · Analysts
Jan 2023
11 Jan · Analysts
Dec 2022
Nov 2022
Oct 2022